Vanflyta Approved for FLT3-ITD Positive Acute Myeloid Leukemia
The FDA has approved Vanflyta (quizartinib) plus chemotherapy for adults with newly diagnosed AML that is FLT3-ITD positive.
Source: empr.com
Page 45 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
– Key Initiatives Highlight the Role of Catalytic Collaboration to Help Advance Health Equity – – Latest HIV Research and Development Data Drive the Next Wave of Person-Centric Scientific Discovery in Treatment, Prevention and Novel Research Strategies in HIV Cure –
Source: marketscreener.com
Long Term Phase 3 Data Published in Arthritis & Rheumatology Shows LUPKYNIS® (voclosporin) Preserved Kidney Function Up to Three Years in Lupus Nephritis Patients with No New or Unexpected Adverse Events
Aurinia Pharmaceuticals Inc. today announced that full results from the Phase 3, double-blind, placebo-controlled AURORA 2 extension study were published online in Arthritis & Rheumatology, the...
Source: marketscreener.com
Coherus and Superior Biologics Announce National
First formal distribution agreement for YUSIMRY™, a biosimilar of Humira®, at $995 per carton (two 40 mg/0.8 mL autoinjectors) representing a discount of...
Source: globenewswire.com
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
YUSIMRY™ (adalimumab-aqvh) product image REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) and…
Source: sina.com.hk